Open Access Green as soon as Postprint is submitted to ZB.
Reply to: Safety of dopamine agonists for treating restless legs syndrome.
Mov. Disord. 34, 150-151 (2019)
Edit extra informations Login
Publication type Article: Journal article
Document type Letter to the Editor
Institute(s) Institute of Neurogenomics (ING)